Summary of Activity with NCM Included in Company's Condensed Consolidated Financial Statements (Detail) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Schedule of Equity Method Investments [Line Items]
Equity in earnings		$ 11,047	$ 10,328	$ 20,372	$ 17,548
Equity in other comprehensive income		(72)	466	(3,010)	862
Other Comprehensive Loss
Schedule of Equity Method Investments [Line Items]
Ending Balance		2,734		2,734
Cash Received
Schedule of Equity Method Investments [Line Items]
Revenues earned under ESA	[1]			8,478
Receipt of excess cash distributions				20,622
Receipt under tax receivable agreement				4,113
Ending Balance		33,213		33,213
Other Revenue
Schedule of Equity Method Investments [Line Items]
Revenues earned under ESA	[1]			(8,478)
Ending Balance		(14,805)		(14,805)
Equity in Earnings
Schedule of Equity Method Investments [Line Items]
Ending Balance		(6,672)		(6,672)
Distributions from NCM
Schedule of Equity Method Investments [Line Items]
Receipt of excess cash distributions				(10,859)
Receipt under tax receivable agreement				(2,241)
Ending Balance		(13,100)		(13,100)
Investment In NCM
Schedule of Equity Method Investments [Line Items]
Beginning Balance				178,939
Receipt of common units due to annual common unit adjustment				15,421
Receipt of excess cash distributions				(9,763)
Receipt under tax receivable agreement				(1,872)
Equity in earnings				6,672
Equity in other comprehensive income				(2,734)
Ending Balance		186,663		186,663
Deferred Revenue
Schedule of Equity Method Investments [Line Items]
Receipt of common units due to annual common unit adjustment				15,421
Beginning Balance				(335,219)
Ending Balance		(344,313)		(344,313)
NCM
Schedule of Equity Method Investments [Line Items]
Beginning Balance				178,939
Equity in earnings		6,263	$ 5,389	6,672	$ 5,746
Ending Balance		186,663		186,663
Beginning Balance				(335,219)
Ending Balance		$ (344,313)		(344,313)
NCM | Other Comprehensive Loss
Schedule of Equity Method Investments [Line Items]
Equity in other comprehensive income				2,734
NCM | Other Revenue
Schedule of Equity Method Investments [Line Items]
Amortization of deferred revenue				6,327
NCM | Equity in Earnings
Schedule of Equity Method Investments [Line Items]
Equity in earnings				(6,672)
NCM | Deferred Revenue
Schedule of Equity Method Investments [Line Items]
Amortization of deferred revenue				$ 6,327

[1] Amount includes the per patron and per digital screen theatre access fees due to the Company, net of amounts due to NCM for on-screen advertising time provided to the Company's beverage concessionaire of approximately $0.